0001161697-22-000400.txt : 20220819 0001161697-22-000400.hdr.sgml : 20220819 20220819170319 ACCESSION NUMBER: 0001161697-22-000400 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220818 FILED AS OF DATE: 20220819 DATE AS OF CHANGE: 20220819 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Miller Steve CENTRAL INDEX KEY: 0001402535 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33057 FILM NUMBER: 221181509 MAIL ADDRESS: STREET 1: 220 MIRACLE MILE STREET 2: SUITE 234 CITY: CORAL GABLES STATE: FL ZIP: 33134 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CATALYST PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001369568 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 BUSINESS PHONE: (305) 529-2522 MAIL ADDRESS: STREET 1: 355 ALHAMBRA CIRCLE STREET 2: SUITE 801 CITY: CORAL GABLES STATE: FL ZIP: 33134 FORMER COMPANY: FORMER CONFORMED NAME: CATALYST PHARMACEUTICAL PARTNERS, INC. DATE OF NAME CHANGE: 20110215 FORMER COMPANY: FORMER CONFORMED NAME: Catalyst Pharmaceutical Partners, Inc. DATE OF NAME CHANGE: 20060719 4 1 form4.xml FORM 4 FOR 08-18-2022 X0306 4 2022-08-18 0 0001369568 CATALYST PHARMACEUTICALS, INC. CPRX 0001402535 Miller Steve 355 ALHAMBRA CIRCLE, SUITE 801 CORAL GABLES FL 33134 0 1 0 0 Chief Operating Officer Common stock, par value $0.001 per share 2022-08-18 4 M 0 118575 2.53 A 880299 D Common stock, par value $0.001 per share 2022-08-18 4 S 0 118575 13.559 D 761724 D Common stock, par value $0.001 per share 2022-08-18 4 M 0 31425 2.53 A 793149 D Common Stock, par value $0.001 per share 2022-08-18 4 S 0 31425 13.434 D 761724 D Options to purchase common stock 2.53 2022-08-18 4 A 0 118575 0 D 2022-12-30 Common Stock 118575 1492425 D Options to purchase common stock 2.53 2022-08-18 4 A 0 31425 0 D 2022-12-30 Common Stock 31425 1461000 D Shares were sold in various lots from $13.37 to $13.66 per share. The listed sales price represents a weighted average price for the shares sold. Shares were sold in various lots from $13.30 to $13.54 per share. The listed sales price represents a weighted average price for the shares sold. Shares were sold to cover exercise price of options, tax withholding requirements (if applicable) and for personal reasons. Shares were not sold as a result of any disagreement with the Company and Dr. Miller remains an officer of the Company. Options vested in three annual tranches beginning on December 30, 2016. /s/ Steve Miller 2022-08-19